NOS3 and metabolic dysfunction-associated steatotic liver disease: In conclusion, we have demonstrated that in vivo liver MRI and 1H‐MRS can noninvasively stage the early stages in the development of NAFLD and monitor treatment response after administration of Met in an eNOS−/− murine model of NAFLD.